Lupus & antiphospholipid syndrome
Reporting of determinants of health inequities and participant characteristics in randomized controlled trials of systemic lupus erythematosus in Canada: A scoping review
Authors' conclusion
Limited reporting of determinants of health inequities in RCTs for SLE in Canada suggests the need for reporting standards to support equity, diversity, and inclusion practices in research.
Study context
- Population
- RCTs of pharmacologic and non-pharmacologic interventions in systemic lupus erythematosus (SLE) patients aged ≥18 years conducted in Canada; MEDLINE (Ovid) and Embase (1990 to June 2023), CENTRAL (inception to June 2023)6 RCTs
- Outcome
- Reporting of participant characteristics relevant to health inequities (11 PROGRESS-Plus factors)
Methodological detailsPROGRESS-Plus framework data extraction
- PROGRESS-Plus framework data extraction
Main finding
As reported in the abstract
Reporting of PROGRESS-Plus factors in included RCTs
- Studies included (of 1901 unique records)
- 6
- Female participants
- 84.4% to 100%
- Mean age range of participants
- 42 to 52.3 years
- Place of residence, race, education and social capital: studies reporting
- three
- Socioeconomic status: studies reporting
- two
- Occupation: studies reporting
- one
Original publication
Reporting of determinants of health inequities and participant characteristics in randomized controlled trials of systemic lupus erythematosus in Canada: A scoping review. Lupus. Published 9 February 2024. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →